ABCL

#2041
AbCellera Biologics Inc. Common Shares
3.61
+3.74%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
3.61
3.61
Jahresspanne
1.89
6.52
Tagesänderung
+3.74%
Monatliche Änderung
-10.86%
6 month change
-18.51%
Jahresänderung
+32.72%
Vorheriger Schlusskurs
3.48
Open
3.61
Bid
Ask
Low
3.61
High
3.61
Volumen
47
Open full chart

Financials

Overview Finanzbericht Statistics Dividends
Quarterly Annual
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM

AbCellera Biologics Inc

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Nachrichten